company background image
JPH logo

Jerusalem Pharmaceuticals PLSE:JPH Stock Report

Last Price

US$3.65

Market Cap

US$65.7m

7D

0%

1Y

-8.8%

Updated

12 Jun, 2024

Data

Company Financials

Jerusalem Pharmaceuticals Co. Ltd.

PLSE:JPH Stock Report

Market Cap: US$65.7m

JPH Stock Overview

Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.

JPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Jerusalem Pharmaceuticals Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jerusalem Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.65
52 Week HighUS$4.00
52 Week LowUS$3.50
Beta0.13
1 Month Change-4.20%
3 Month Change-3.95%
1 Year Change-8.75%
3 Year Change35.69%
5 Year Change25.86%
Change since IPO196.52%

Recent News & Updates

Recent updates

Shareholder Returns

JPHPS PharmaceuticalsPS Market
7D0%1.2%0.3%
1Y-8.8%3.8%-15.5%

Return vs Industry: JPH underperformed the PS Pharmaceuticals industry which returned 3.8% over the past year.

Return vs Market: JPH exceeded the PS Market which returned -15.5% over the past year.

Price Volatility

Is JPH's price volatile compared to industry and market?
JPH volatility
JPH Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement3.6%
10% most volatile stocks in PS Market5.4%
10% least volatile stocks in PS Market2.7%

Stable Share Price: JPH has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine JPH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969523Mohammed Mahmoud Masroujiwww.jepharm.ps

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions.

Jerusalem Pharmaceuticals Co. Ltd. Fundamentals Summary

How do Jerusalem Pharmaceuticals's earnings and revenue compare to its market cap?
JPH fundamental statistics
Market capUS$65.70m
Earnings (TTM)US$6.96m
Revenue (TTM)US$39.65m

9.4x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JPH income statement (TTM)
RevenueUS$39.65m
Cost of RevenueUS$18.07m
Gross ProfitUS$21.59m
Other ExpensesUS$14.63m
EarningsUS$6.96m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin54.44%
Net Profit Margin17.54%
Debt/Equity Ratio2.4%

How did JPH perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

26%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.